Venture Kick

Clee Medical specializes in developing innovative neuroimaging and surgical access technologies to improve precision and efficiency in neurosurgery. Their products, which include imaging and sensing systems, provide enhanced access, vision, and navigation within the brain, seamlessly integrating with existing neurosurgical equipment and current surgical routines. This enables healthcare providers to potentially enhance patient outcomes with greater precision.

Lighthouse Tech specializes in developing smart assistive eyewear frames equipped with advanced radar sensing technology. These frames help individuals who are blind or visually impaired detect obstacles at the upper-body level, enhancing their mobility and reducing collision risks.

ValTech Lifesciences is a medtech startup promoting cardiovascular health through its proprietary heart valve characteristics that improve the performance of mechanical and biological prostheses.

dEEGtal’s use of AI to expedite epilepsy diagnosis could make a significant difference in patient care, by analyzing EEG data quickly, it might help identify patterns or anomalies that could be missed by human reviewers alone.

Regenosca SA is a Swiss company based in Lausanne, established in 2019, that specializes in the development and commercialization of innovative medical devices for bladder reconstruction. The company focuses on creating sterile, off-the-shelf implants that serve as viable alternatives to autologous tissue substitutes for soft tissue repair. By leveraging advanced biomaterials technology, Regenosca aims to facilitate regeneration rather than scarring, thereby enhancing patient outcomes and preserving bladder function. Their products are designed to be easy to use, ultimately improving the quality of life for patients undergoing bladder surgeries.

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Transpire Bio is a biotechnology platform focused on the development of inhaled therapeutics aimed at improving healthcare outcomes globally. The company specializes in the commercialization of lower-cost generic alternatives for injectable drugs, utilizing innovative delivery methods to enhance patient experience by providing painless administration. Transpire Bio's product portfolio includes medicines and inhalation therapies targeting both lung diseases and systemic conditions, reflecting its commitment to addressing a wide range of health challenges through advanced biopharmaceutical solutions.

AlpineWell developing novel solutions to hunger and swallowing difficulties, AlpineWell produces patient-centric food for special medicinal purposes (FSMP) and also provides automatic nutrition tracking to detect malnutrition early on.

CompagOs is a company dedicated to improving cancer treatment outcomes by providing personalized solutions for patients with bone cancer. The company utilizes 3D bioprinting technology to recreate the unique cancerous conditions of a patient's bone in a controlled laboratory environment, allowing oncologists to assess different drug reactions and determine the most effective treatment options. By using mineralized three-dimensional bio-printed bone organoids, CompagOs surpasses the limitations of conventional animal and 2D models, offering a more accurate representation of human physiological conditions. This technology not only aids in personalized patient care but also serves as a powerful tool for drug development, enabling researchers to evaluate drug efficacy in a realistic and patient-relevant setting.

Sensawear is a medical technology company that specializes in the production of wearable, textile-integrated sensors. These sensors monitor tissue oxygenation and skin pressure in real-time, alerting users to potential pressure injuries before they occur. By providing early warnings of low-oxygenation conditions caused by high-pressure points, Sensawear's products enable users to take preventative action, such as moving or being moved, thus minimizing the risk of painful and dangerous pressure ulcers.

SightIn Health develops artificial intelligence-powered software for portable ultrasound, providing image analytics, usage guidance, and interpretation to support patient diagnosis. The platform automates quality assessment, ultrasound probe guidance, and image analysis, lowering the skill barrier required to operate ultrasound equipment and capture medical images for diagnostics and prognostics. Founded in 2021 and based in Geneva, Switzerland, SightIn Health targets healthcare providers seeking accurate, AI-assisted medical image analysis.

Suri Biotech is a biotechnology company specializing in the development of targeted bacterial strains aimed at alleviating bloating and intestinal discomfort. Its proprietary strains reduce hydrogen gas production by intestinal microorganisms, with potential applications in various functional gastrointestinal disorders.

Avelo focuses on saving lives through swift and precise infectious disease diagnoses in primary care settings. It specializes in manufacturing breath aerosol diagnostic equipment designed to enhance tuberculosis diagnosis via a non-invasive, painless breath collection device. This enables faster, accurate diagnoses using existing PCR testing infrastructure, facilitating earlier appropriate treatment and rapid patient referral.

Sensemodi develops a smart wearable that uses AI to analyze thermal, acoustic, and kinematic data to assess joint health. The device is designed to monitor knees and other joints with multiple sensor modalities, enabling users to check and track joint condition anywhere. By providing quick assessments and ongoing monitoring, Sensemodi aims to help prevent disability and reduce the socioeconomic burden of musculoskeletal disorders and support improved healthcare treatment.

Oncobit specializes in developing precise diagnostic tests and monitoring tools to enhance personalized cancer care. Its platform analyzes patient samples, offering clinicians advanced molecular insights to optimize therapy management.

CompagOs is a company dedicated to improving cancer treatment outcomes by providing personalized solutions for patients with bone cancer. The company utilizes 3D bioprinting technology to recreate the unique cancerous conditions of a patient's bone in a controlled laboratory environment, allowing oncologists to assess different drug reactions and determine the most effective treatment options. By using mineralized three-dimensional bio-printed bone organoids, CompagOs surpasses the limitations of conventional animal and 2D models, offering a more accurate representation of human physiological conditions. This technology not only aids in personalized patient care but also serves as a powerful tool for drug development, enabling researchers to evaluate drug efficacy in a realistic and patient-relevant setting.

Biped.ai develops an AI-powered mobility companion for visually impaired individuals. Their device, worn as a belt or attached to a white cane, uses autonomous navigation technology and spatial hearing to provide intuitive feedback via sound and vibrations, helping users locate obstacles.

Nemosia is a company focused on the development of positron emission tomography (PET) tracers aimed at diagnosing neurological disorders. Utilizing advanced technology, Nemosia creates tracers that facilitate the early detection of neurodegenerative diseases by visualizing N-methyl-D-aspartate (NMDA) receptors in the brain. This innovative approach allows for timely intervention, enabling patients to take proactive measures against neurological conditions. Through its specialized PET imaging capabilities, Nemosia contributes to improved diagnostic accuracy and better patient outcomes in the field of neurology.

ArcoScreen is a Swiss medtech company developing a microfluidic discovery platform for drug screening that targets membrane receptors, notably G-protein coupled receptors. The platform blends a lab-on-chip system with biological assays to quantify GPCR activation in primary mammalian cells, including guanosine 5'-O-(3-thiotriphosphate)-based functional readouts, and supports both ready-to-use and custom stable cell lines. This approach enables pharmaceutical researchers to investigate receptor signaling, identify drug modes of action, and perform in-vitro screenings directly on patient-derived cells. By enabling faster, more predictive screenings, ArcoScreen aims to reduce clinical attrition and accelerate the development of therapeutic candidates with improved translational relevance.

CompagOs is a company dedicated to improving cancer treatment outcomes by providing personalized solutions for patients with bone cancer. The company utilizes 3D bioprinting technology to recreate the unique cancerous conditions of a patient's bone in a controlled laboratory environment, allowing oncologists to assess different drug reactions and determine the most effective treatment options. By using mineralized three-dimensional bio-printed bone organoids, CompagOs surpasses the limitations of conventional animal and 2D models, offering a more accurate representation of human physiological conditions. This technology not only aids in personalized patient care but also serves as a powerful tool for drug development, enabling researchers to evaluate drug efficacy in a realistic and patient-relevant setting.

CustomSurg is a company focused on enhancing the treatment of complex bone fractures, particularly those involving joints. It develops fracture-specific bone plates that are tailored to match the unique anatomy of individual patients using advanced technologies such as computer tomography and 3D printing. This personalized approach provides improved stability for bone repairs, which can significantly reduce surgery time and lower long-term healthcare costs for patients. By offering a software solution for optimized surgical planning and designing patient-specific implants and instruments, CustomSurg shifts the treatment strategy from a subjective to an objective framework, aiming to improve outcomes for approximately 400,000 trauma patients in a market valued at $1.2 billion. The involvement of a Harvard Medical School surgeon in directing the medical aspects of the company adds a layer of credibility to its innovative offerings.

condenZero GmbH, established in 2019 and headquartered in Zurich, Switzerland, specializes in the development and production of scientific instruments and components. These are designed for research applications in ultra-high vacuum and cryogenic conditions, with a focus on liquid helium transmission electron microscopy (TEM) technology. The company's platform includes cryogenic and ultra-high vacuum sample holders, along with engineering services, enabling research institutions and laboratories to conduct precise low-temperature experiments and achieve high-resolution imaging.

Neurosoft Bioelectronics specializes in developing soft, implantable electrodes designed to interface with nervous tissues. Their flagship product, SOFT ECoG, is a subdural electrode used for recording and stimulating the brain's surface, offering improved recordings, reduced current speed, minimized MRI artifacts, enhanced bio-integration, and precise anatomical targeting.

Rea Diagnostics specializes in developing non-invasive diagnostic technology aimed at assessing the risk of preterm birth. The company's primary product is a smart pad equipped with an embedded sensor that detects proteins indicative of labor. This device incorporates a microfluidic system, a biosensing unit, and a readout system, enabling the identification and quantification of biomarkers present in vaginal fluid. The results are communicated through a mobile application, allowing healthcare professionals to make timely and informed decisions regarding the risk of premature birth. Headquartered in Lausanne, Switzerland, Rea Diagnostics addresses the need for more efficient diagnostics in the preterm birth market, ultimately supporting better outcomes for mothers and infants.

Regenosca SA is a Swiss company based in Lausanne, established in 2019, that specializes in the development and commercialization of innovative medical devices for bladder reconstruction. The company focuses on creating sterile, off-the-shelf implants that serve as viable alternatives to autologous tissue substitutes for soft tissue repair. By leveraging advanced biomaterials technology, Regenosca aims to facilitate regeneration rather than scarring, thereby enhancing patient outcomes and preserving bladder function. Their products are designed to be easy to use, ultimately improving the quality of life for patients undergoing bladder surgeries.

CustomSurg is a company focused on enhancing the treatment of complex bone fractures, particularly those involving joints. It develops fracture-specific bone plates that are tailored to match the unique anatomy of individual patients using advanced technologies such as computer tomography and 3D printing. This personalized approach provides improved stability for bone repairs, which can significantly reduce surgery time and lower long-term healthcare costs for patients. By offering a software solution for optimized surgical planning and designing patient-specific implants and instruments, CustomSurg shifts the treatment strategy from a subjective to an objective framework, aiming to improve outcomes for approximately 400,000 trauma patients in a market valued at $1.2 billion. The involvement of a Harvard Medical School surgeon in directing the medical aspects of the company adds a layer of credibility to its innovative offerings.

Founded in 2020, Bota Systems specializes in developing and manufacturing sensors for robotic arms, exoskeletons, prosthetic devices, and surgery platforms. Its product portfolio includes force torque sensors designed to enable robots to interact safely and naturally with their environment.

condenZero GmbH, established in 2019 and headquartered in Zurich, Switzerland, specializes in the development and production of scientific instruments and components. These are designed for research applications in ultra-high vacuum and cryogenic conditions, with a focus on liquid helium transmission electron microscopy (TEM) technology. The company's platform includes cryogenic and ultra-high vacuum sample holders, along with engineering services, enabling research institutions and laboratories to conduct precise low-temperature experiments and achieve high-resolution imaging.

peakPCR develops Polymerase Chain Reaction (PCR) devices for research and private laboratories. peakPCR is a low-cost, small size device capable of performing real-time polymerase chain reaction (qPCR). PCR is a method widely used in molecular biology to duplicate DNA segments, with applications such as genotyping, mutation detection, forensics, and paternity testing. The Polymerase Chain Reaction (PCR) is a widely used molecular technique to make millions of copies of a DNA sample, with applications in a variety of fields such as medical diagnostics, biotechnology, and forensic sciences. We have analyzed the heat transfer limitations of conventional PCR machines. This has led to the design of a completely new sample holder with extremely high heating and cooling rates and a much lower sample volume, in order to cut analysis time from currently 1-2 h down to 10 minutes, and reagent consumption by 90%. Next to a first stand-alone desktop instrument, we have also developed a portable version that is battery-powered and that operates in conjunction with a smartphone. We aim to deploy these PCR devices to research and private laboratories at affordable prices.

Aseptuva is an early-stage MedTech company based in Technopark Winterthur. It aims to combat Healthcare-Associated Infections (HAI) by developing medical devices for in-situ disinfection of various catheters, preventing infections at their source and potentially saving thousands of lives annually.

No-Touch Robotics specializes in developing advanced robotic grippers that operate without mechanical contact. Utilizing ultrasound-generated pressure fields, the company's solutions enable precise, damage-free manipulation of objects across various industries.

CustomSurg is a company focused on enhancing the treatment of complex bone fractures, particularly those involving joints. It develops fracture-specific bone plates that are tailored to match the unique anatomy of individual patients using advanced technologies such as computer tomography and 3D printing. This personalized approach provides improved stability for bone repairs, which can significantly reduce surgery time and lower long-term healthcare costs for patients. By offering a software solution for optimized surgical planning and designing patient-specific implants and instruments, CustomSurg shifts the treatment strategy from a subjective to an objective framework, aiming to improve outcomes for approximately 400,000 trauma patients in a market valued at $1.2 billion. The involvement of a Harvard Medical School surgeon in directing the medical aspects of the company adds a layer of credibility to its innovative offerings.

XRnanotech is a Swiss company that designs and manufactures nanostructured X-ray optics for high-energy beams. It develops high aspect ratio Fresnel zone plates, beam-shaping condensers for X-ray microscopy, 2D and 3D resolution targets, gratings and beam splitters, and custom optics for advanced experiments. Its technology enables precise focusing of very energetic X-rays onto tiny samples, supporting drug discovery, medical imaging, microchip inspection, and investigations of advanced materials. Founded in 2020 and based in Untersiggenthal, XRnanotech positions itself as a deep tech provider delivering precision optics for high-tech applications. The company offers capabilities in custom optics design and analytical components used in research and industry.

Founded in Lausanne in 2019 by Théo-Tim Denisart and Roberto Costa, Helvitek Labs develops innovative anti-pollution face masks. Initially inspired by pollution experiences in China, the company aims to improve comfort and protection for health professionals using AI-driven sealing technology.

LifeMatrix is a biotechnology company focused on the development of biomimetic implants and bio-engineering technologies aimed at treating cardiovascular diseases and facilitating the growth of human replacement tissues. The company specializes in human cell-derived, off-the-shelf tissue-engineered implants that integrate with the patient's body post-implantation, allowing them to grow and regenerate. This innovative approach addresses the limitations of traditional implants, promoting faster recovery and improved outcomes for patients. LifeMatrix's technology is supported by over 20 years of research, resulting in more than 100 peer-reviewed publications and extensive preclinical studies demonstrating safety and efficacy, paving the way for clinical applications. The company's advancements are bolstered by various national and international research grants, reflecting its commitment to transforming the field of regenerative medicine.

Founded in 2020, Emovo Care is a Swiss medical device company specializing in robotic orthoses for individuals with hand motor impairments, particularly those resulting from stroke. Their flagship product is an active orthosis that enables hemiparetic stroke patients to regain hand movement at home.

Founded in 2019, epyMetrics is a Swiss health technology company specializing in wearable solutions for continuous, non-invasive monitoring of thermoregulation. Its diagnostic wearables detect early signs of heat stress, enhancing occupational safety and reducing workplace costs.

Regenosca SA is a Swiss company based in Lausanne, established in 2019, that specializes in the development and commercialization of innovative medical devices for bladder reconstruction. The company focuses on creating sterile, off-the-shelf implants that serve as viable alternatives to autologous tissue substitutes for soft tissue repair. By leveraging advanced biomaterials technology, Regenosca aims to facilitate regeneration rather than scarring, thereby enhancing patient outcomes and preserving bladder function. Their products are designed to be easy to use, ultimately improving the quality of life for patients undergoing bladder surgeries.

STIMIT AG is a medtech company based in Nidau, Switzerland, established in 2018. The company specializes in developing innovative therapies and medical devices aimed at patients who have lost their natural breathing function, particularly those on mechanical ventilation. STIMIT's proprietary technology non-invasively activates the body's own diaphragm, which is often weakened in such patients. By strengthening diaphragm function, the company seeks to facilitate the liberation of patients from ventilators, thereby reducing the time spent on ventilation and improving overall patient outcomes. Additionally, STIMIT is working on second-generation therapies that aim to further enhance the inhalation process for patients. Through these advancements, STIMIT is positioned to significantly impact intensive care practices and improve the quality of life for patients with respiratory challenges.

Founded in 2020, SurgeonsLab specializes in developing patient-specific training models for surgical procedures. It offers microsurgical treatment planning, procedure planning, and validation of new medical devices to enhance precision and safety in surgeries.

EarlySight, a Lausanne-based medical device company, develops technology to detect and treat eye diseases at an early stage. Its flagship work includes a fundus camera that images the retina with high detail by combining eye illumination with real time ocular aberration correction. The company also leverages cellular level imaging and transscleral illumination to monitor day to day treatment effects in a non invasive manner, enabling eye specialists to visualize the morphology of retinal cells. Founded in 2016, EarlySight aims to bring its imaging technology to clinics to improve early diagnosis and treatment of ocular conditions.

Selph is a medical technology company that focuses on developing a medical device that enables people to conduct a self-test for sexually transmitted diseases. It specializes in digital health, sensors, diagnostics, and medical services.

Terapet specializes in advanced proton therapy for cancer treatment. Founded by physicists Christina Vallgren, Marcus Palm, and Professor Raymond Miralbell from Geneva University Hospitals, the company offers precise radiotherapy that minimizes harm to healthy cells. Incorporated in 2019, Terapet is based in Geneva, Switzerland.

Testmate Health is a medtech startup and award-winning spin-off of the University of Geneva in Switzerland. It has developed a smartphone-compatible platform test kit capable of diagnosing diseases based on identifiable DNA or RNA sequences without the need for a laboratory, delivering results in minutes at home. The initial product is a rapid urine self-test for the four most common sexually transmitted infections, designed to be used outside clinical settings and to provide a smartphone-scanable result that supports immediate access to treatment if needed. The platform uses DNA isothermal technology to detect infectious diseases with identifiable DNA, enabling home testing without laboratory submission. Further test kits for additional diseases are in development to empower users to monitor their health from home.

Neurosoft Bioelectronics specializes in developing soft, implantable electrodes designed to interface with nervous tissues. Their flagship product, SOFT ECoG, is a subdural electrode used for recording and stimulating the brain's surface, offering improved recordings, reduced current speed, minimized MRI artifacts, enhanced bio-integration, and precise anatomical targeting.

XRnanotech is a Swiss company that designs and manufactures nanostructured X-ray optics for high-energy beams. It develops high aspect ratio Fresnel zone plates, beam-shaping condensers for X-ray microscopy, 2D and 3D resolution targets, gratings and beam splitters, and custom optics for advanced experiments. Its technology enables precise focusing of very energetic X-rays onto tiny samples, supporting drug discovery, medical imaging, microchip inspection, and investigations of advanced materials. Founded in 2020 and based in Untersiggenthal, XRnanotech positions itself as a deep tech provider delivering precision optics for high-tech applications. The company offers capabilities in custom optics design and analytical components used in research and industry.

Founded in 2020, Bota Systems specializes in developing and manufacturing sensors for robotic arms, exoskeletons, prosthetic devices, and surgery platforms. Its product portfolio includes force torque sensors designed to enable robots to interact safely and naturally with their environment.

C-MedTec is a company focused on enhancing the detection and monitoring of brain concussions through innovative technology. It has developed a specialized helmet that serves as a medical imaging modality capable of measuring brain metabolism and identifying abnormal neurological behavior following a traumatic impact. This advancement addresses the significant gap in concussion diagnosis, which traditionally relies on subjective assessments by trained professionals. By providing early detection and diagnosis, C-MedTec aims to promote safer sports practices and mitigate the risk of long-term effects and chronic conditions such as Alzheimer's disease and chronic traumatic encephalopathy (CTE). Through its cutting-edge approach, the company seeks to improve health outcomes for athletes and individuals at risk of brain trauma.

Autonomyo is a Swiss company founded in 2014, based in Lausanne, that specializes in developing robotic rehabilitation solutions for individuals with neurological gait disorders. The company focuses on manufacturing a lightweight exoskeleton designed to facilitate robotically assisted gait training, which can be utilized in rehabilitation clinics as well as in home settings with remote monitoring capabilities. Autonomyo's team, comprised of engineers, developers, and healthcare professionals, is dedicated to enhancing accessibility and training intensity for people with neuromuscular and motor disorders, ultimately aiming to improve their mobility and restore their freedom of movement.

KOVE is a medical technology company focused on prenatal care. It has developed an implantable device that closes and secures the hole created by endoscopes in the fetal membrane during fetoscopy, preventing membrane rupture. By reducing this procedure-related risk, the device enables doctors to perform more fetal treatments during pregnancy and lowers the chance of preterm birth. Described as a medtech spin-off, KOVE aims to advance prenatal procedures by mitigating complications associated with fetal interventions.

Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.

Frater.swiss is engaged in the development and production of innovative devices and applications designed for out-of-hospital care, with a particular focus on hypothermic patients. The company creates products that assist healthcare professionals in high-stress environments, including emergency medicine, military medicine, expedition medicine, and veterinary medicine. Their offerings provide efficient measures for assessing hypothermia and stabilizing patient temperature through warm infusion, thereby enhancing the quality of medical care available in critical situations. Frater.swiss aims to empower medical personnel to effectively save lives outside traditional hospital settings.

Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.

Yago enables independence for people with hand motor impairments. Yago is a portable exoskeleton to support independence in daily living for people with hand motor impairments.

KaleiBox is a company based in Zurich, Switzerland, specializing in the development of three-dimensional optical imaging devices specifically designed for small-animal imaging. It offers two main products: the standalone-mode KaleiBox and a hybrid-mode KaleiBox, both of which facilitate fluorescence tomography with an emphasis on compact hardware design and advanced software. The company's devices serve various applications, including research laboratories, biotechnological industries, agricultural diagnostics, and image-guided surgical procedures. Drawing inspiration from the kaleidoscope, KaleiBox focuses on versatility and portability, aiming to enhance the current workflow in 3D fluorescence imaging, particularly for preclinical studies.

Auxivo AG is a Swiss company based in Zürich that specializes in the development and manufacturing of wearable exoskeletons. These innovative devices are designed to support and protect workers engaged in physically demanding tasks, such as lifting and carrying heavy objects. By reducing the physical strain and fatigue associated with such work, Auxivo's products aim to enhance worker safety and well-being, ultimately minimizing the risk of injuries. The company's focus on creating accessible exoskeletons underscores its commitment to improving workplace conditions and ensuring the long-term health of its users.

Yago enables independence for people with hand motor impairments. Yago is a portable exoskeleton to support independence in daily living for people with hand motor impairments.

STIMIT AG is a medtech company based in Nidau, Switzerland, established in 2018. The company specializes in developing innovative therapies and medical devices aimed at patients who have lost their natural breathing function, particularly those on mechanical ventilation. STIMIT's proprietary technology non-invasively activates the body's own diaphragm, which is often weakened in such patients. By strengthening diaphragm function, the company seeks to facilitate the liberation of patients from ventilators, thereby reducing the time spent on ventilation and improving overall patient outcomes. Additionally, STIMIT is working on second-generation therapies that aim to further enhance the inhalation process for patients. Through these advancements, STIMIT is positioned to significantly impact intensive care practices and improve the quality of life for patients with respiratory challenges.

KOVE is a medical technology company focused on prenatal care. It has developed an implantable device that closes and secures the hole created by endoscopes in the fetal membrane during fetoscopy, preventing membrane rupture. By reducing this procedure-related risk, the device enables doctors to perform more fetal treatments during pregnancy and lowers the chance of preterm birth. Described as a medtech spin-off, KOVE aims to advance prenatal procedures by mitigating complications associated with fetal interventions.

Frater.swiss is engaged in the development and production of innovative devices and applications designed for out-of-hospital care, with a particular focus on hypothermic patients. The company creates products that assist healthcare professionals in high-stress environments, including emergency medicine, military medicine, expedition medicine, and veterinary medicine. Their offerings provide efficient measures for assessing hypothermia and stabilizing patient temperature through warm infusion, thereby enhancing the quality of medical care available in critical situations. Frater.swiss aims to empower medical personnel to effectively save lives outside traditional hospital settings.

Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.

Founded in 2019, AnnAidA Technologies specializes in developing innovative devices for biochemical research. Its flagship product, EmbryoSpin, enables chemical analysis at the scale of a single human embryo using microscopic Nuclear Magnetic Resonance technology.

Spectroplast specializes in additive manufacturing of pure silicones using its proprietary SAMT technology. It offers customizable solutions for healthcare, industrial components, soft robotics, art, and medical sectors. Founded in 2018 as a spin-off from ETH Zurich, Spectroplasty enables cost-effective and time-saving production without the need for molds, operating with minimal waste.

Viventis Microscopy develops an innovative light sheet microscope system designed for long-term live imaging of light-sensitive samples, such as embryos and organoids. The company provides both the hardware and custom microscope control software, facilitating advanced imaging capabilities for researchers and organizations. By enabling detailed observation of delicate biological structures, Viventis Microscopy supports efforts in drug development and other scientific endeavors, helping to accelerate research and enhance the understanding of complex biological processes.

ALAnostics is a specialty biopharmaceutical company that originated as a spin-off from the University of Geneva. It focuses on developing innovative tumor painting technology aimed at enhancing the surgical treatment of breast cancer. The company’s proprietary approach utilizes nanomedicines to create a fluorescent dye that targets early-stage tumors, facilitating real-time identification and removal during surgery. This technology, based on 5-ALA prodrugs, supports fluorescence-guided surgical procedures and incorporates light-activated antimicrobials, ultimately improving surgical outcomes and increasing the likelihood of saving patients' lives by ensuring complete tumor removal.

Auxivo AG is a Swiss company based in Zürich that specializes in the development and manufacturing of wearable exoskeletons. These innovative devices are designed to support and protect workers engaged in physically demanding tasks, such as lifting and carrying heavy objects. By reducing the physical strain and fatigue associated with such work, Auxivo's products aim to enhance worker safety and well-being, ultimately minimizing the risk of injuries. The company's focus on creating accessible exoskeletons underscores its commitment to improving workplace conditions and ensuring the long-term health of its users.

b-rayZ is a spin-off from University Hospital Zurich that develops artificial intelligence tools for medical imaging. Its team blends radiologists, data scientists and physicians with extensive experience in imaging and radiology. The company creates predictive deep learning analytics to assess personal medical images and to support radiologists in mammography by providing real-time image quality and breast density assessments. The software enables standardized evaluation of imaging data to improve breast cancer detectability and aims to enhance diagnostic accuracy and efficiency, potentially reducing healthcare costs.

SwissSource Instruments specializes in developing and manufacturing innovative analytical equipment for mass spectrometry. The company’s technology significantly enhances the efficiency of sample preparation, allowing researchers and industry professionals across various sectors—such as pharmaceuticals, food science, and forensics—to analyze complex samples with greater speed and accuracy. By implementing SwissSource’s ionization sources, clients can streamline their analytical processes, reduce the sample volumes required for analysis, and address challenges associated with traditional sample preparation methods. This versatile technology is applicable in multiple fields, including academia, industry, government laboratories, and research institutions, providing solutions that facilitate comprehensive and efficient sample analysis.

DIANA develops new dosimeters for radio diagnostic applications (especially interventional radiology) based on technology developed for high energy physics experiments

Frater.swiss is engaged in the development and production of innovative devices and applications designed for out-of-hospital care, with a particular focus on hypothermic patients. The company creates products that assist healthcare professionals in high-stress environments, including emergency medicine, military medicine, expedition medicine, and veterinary medicine. Their offerings provide efficient measures for assessing hypothermia and stabilizing patient temperature through warm infusion, thereby enhancing the quality of medical care available in critical situations. Frater.swiss aims to empower medical personnel to effectively save lives outside traditional hospital settings.

KOVE is a medical technology company focused on prenatal care. It has developed an implantable device that closes and secures the hole created by endoscopes in the fetal membrane during fetoscopy, preventing membrane rupture. By reducing this procedure-related risk, the device enables doctors to perform more fetal treatments during pregnancy and lowers the chance of preterm birth. Described as a medtech spin-off, KOVE aims to advance prenatal procedures by mitigating complications associated with fetal interventions.

Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.

Founded in 2018, Resistell develops and markets a diagnostic device for phenotypic antibiotic susceptibility testing. Its unique method detects movement caused by living bacterial cells to determine bacterial resistance to antibiotics.

Positrigo develops and manufactures dedicated brain positron emission tomography (PET) scanners. Its mission is to make functional brain imaging accessible for early detection of neurodegenerative diseases like Alzheimer's, Lewy body dementia, vascular dementia, and frontotemporal dementia.

Prediva SA is a Switzerland-based company founded in 2019 that specializes in predictive machine learning software aimed at diagnosing and treating coronary artery disease. The company utilizes a combination of medical image analysis, machine learning models, and computational fluid dynamics simulations to generate personalized 3D physiological models of coronary arteries. This innovative approach allows for the prediction of plaque progression and offers recommendations for stent placement and treatment planning. By providing insightful patient analysis, Prediva enables clinicians to make evidence-based treatment decisions, thereby reducing costs and procedure times while minimizing the need for invasive interventions.

Readily3D is a Lausanne, Switzerland-based company that commercializes volumetric tomographic 3D printers and bioprinting solutions. A spin-off from École Polytechnique Fédérale de Lausanne, it was founded in 2020 after researchers developed tomographic printing methods starting in 2017. The company's printers enable centimeter-scale, tomographic 3D printing of cells and biomaterials with optical resolution below 100 micrometers, and are paired with software that imports design files, optimizes print parameters, and minimizes cell stress and light exposure. This technology supports rapid prototyping of living tissue constructs and statistically meaningful biological models for life sciences research.

Hemolytics is a MedTech company focused on developing innovative diagnostic solutions for malaria detection. The company has created a medical diagnostic device that utilizes a chemical amplification method to enhance the sensitivity of malaria detection. This technology enables the identification of malaria at very early stages, offering a sensitivity that is ten times greater than that of existing rapid diagnostic tests. Hemolytics aims to provide a cost-effective point-of-care diagnostic test kit, utilizing inexpensive reagents to ensure accessibility and effectiveness in various healthcare settings.

Aspivix develops innovative medical devices aimed at enhancing safety and comfort in gynecological procedures. Its flagship product, CAREVIX, employs suction technology to gently stabilize the cervix during procedures, reducing pain and minimizing risks such as bleeding and infections.

Auxivo AG is a Swiss company based in Zürich that specializes in the development and manufacturing of wearable exoskeletons. These innovative devices are designed to support and protect workers engaged in physically demanding tasks, such as lifting and carrying heavy objects. By reducing the physical strain and fatigue associated with such work, Auxivo's products aim to enhance worker safety and well-being, ultimately minimizing the risk of injuries. The company's focus on creating accessible exoskeletons underscores its commitment to improving workplace conditions and ensuring the long-term health of its users.

ALAnostics is a specialty biopharmaceutical company that originated as a spin-off from the University of Geneva. It focuses on developing innovative tumor painting technology aimed at enhancing the surgical treatment of breast cancer. The company’s proprietary approach utilizes nanomedicines to create a fluorescent dye that targets early-stage tumors, facilitating real-time identification and removal during surgery. This technology, based on 5-ALA prodrugs, supports fluorescence-guided surgical procedures and incorporates light-activated antimicrobials, ultimately improving surgical outcomes and increasing the likelihood of saving patients' lives by ensuring complete tumor removal.

MOMM Diagnostics is a Basel-based medical technology company founded in 2018 that develops a novel in vitro diagnostic test and device for the early diagnosis of preeclampsia at the point of care, enabling earlier detection of pregnancy-related risks and improved maternal and fetal management.

ONtrack Diagnostics is a medical technology company based in Zurich, Switzerland, that specializes in creating non-invasive assays aimed at the screening, diagnosis, and monitoring of oncological diseases. The company's initial product is a urine assay designed specifically for the screening of prostate cancer. By focusing on innovative diagnostic solutions, ONtrack Diagnostics seeks to improve patient outcomes in the field of oncology.

DIANA develops new dosimeters for radio diagnostic applications (especially interventional radiology) based on technology developed for high energy physics experiments

Viventis Microscopy develops an innovative light sheet microscope system designed for long-term live imaging of light-sensitive samples, such as embryos and organoids. The company provides both the hardware and custom microscope control software, facilitating advanced imaging capabilities for researchers and organizations. By enabling detailed observation of delicate biological structures, Viventis Microscopy supports efforts in drug development and other scientific endeavors, helping to accelerate research and enhance the understanding of complex biological processes.

Limula develops an automated cell therapy manufacturing platform that combines bioreactor and centrifuge capabilities into a single device, supported by hardware, software, and consumables. The platform enables scalable, decentralized production of cell therapies by bringing manufacturing closer to patients and supporting multiple cell types. It automates complex processing steps within a closed, modular system, allowing biotech and pharmaceutical companies to move from open, manual methods to automated operations, improving efficiency, safety, and accessibility of personalized treatments.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Touchless Automation GmbH is a high-tech company based in Biel/Bienne, Switzerland, specializing in the manufacture of contactless handling equipment for the manipulation, assembly, and inspection of small components, particularly in the fields of optoelectronics, MEMS, and micro-optics. Founded in 2016, the company offers innovative products such as Levio, an automatic die sorter that efficiently picks components from adhesive tapes, and Paradigma, a platform designed for pick-and-place operations that eliminates the need for physical contact with components. Touchless Automation's technology is applicable in various industries, including aerospace, semiconductors, luxury watches, microsystems, and medtech, significantly enhancing production efficiency and yield by facilitating the handling of components ranging from 0.1 to 20 millimeters.

Prediva SA is a Switzerland-based company founded in 2019 that specializes in predictive machine learning software aimed at diagnosing and treating coronary artery disease. The company utilizes a combination of medical image analysis, machine learning models, and computational fluid dynamics simulations to generate personalized 3D physiological models of coronary arteries. This innovative approach allows for the prediction of plaque progression and offers recommendations for stent placement and treatment planning. By providing insightful patient analysis, Prediva enables clinicians to make evidence-based treatment decisions, thereby reducing costs and procedure times while minimizing the need for invasive interventions.

Founded in 2019, AnnAidA Technologies specializes in developing innovative devices for biochemical research. Its flagship product, EmbryoSpin, enables chemical analysis at the scale of a single human embryo using microscopic Nuclear Magnetic Resonance technology.

Positrigo develops and manufactures dedicated brain positron emission tomography (PET) scanners. Its mission is to make functional brain imaging accessible for early detection of neurodegenerative diseases like Alzheimer's, Lewy body dementia, vascular dementia, and frontotemporal dementia.

Founded in 2018, Resistell develops and markets a diagnostic device for phenotypic antibiotic susceptibility testing. Its unique method detects movement caused by living bacterial cells to determine bacterial resistance to antibiotics.

Viventis Microscopy develops an innovative light sheet microscope system designed for long-term live imaging of light-sensitive samples, such as embryos and organoids. The company provides both the hardware and custom microscope control software, facilitating advanced imaging capabilities for researchers and organizations. By enabling detailed observation of delicate biological structures, Viventis Microscopy supports efforts in drug development and other scientific endeavors, helping to accelerate research and enhance the understanding of complex biological processes.

ONtrack Diagnostics is a medical technology company based in Zurich, Switzerland, that specializes in creating non-invasive assays aimed at the screening, diagnosis, and monitoring of oncological diseases. The company's initial product is a urine assay designed specifically for the screening of prostate cancer. By focusing on innovative diagnostic solutions, ONtrack Diagnostics seeks to improve patient outcomes in the field of oncology.

CorasMedical is the development, production and sale of medical devices. It may set up branches and agencies at home and abroad, set up subsidiaries, participate in other ventures, acquire, manage and dispose of intellectual property and real estate, and enter into all business and contracts that directly or indirectly promote the purpose of the Company or which concern the investment and management of the Company's assets.

Aspivix develops innovative medical devices aimed at enhancing safety and comfort in gynecological procedures. Its flagship product, CAREVIX, employs suction technology to gently stabilize the cervix during procedures, reducing pain and minimizing risks such as bleeding and infections.

Touchless Automation GmbH is a high-tech company based in Biel/Bienne, Switzerland, specializing in the manufacture of contactless handling equipment for the manipulation, assembly, and inspection of small components, particularly in the fields of optoelectronics, MEMS, and micro-optics. Founded in 2016, the company offers innovative products such as Levio, an automatic die sorter that efficiently picks components from adhesive tapes, and Paradigma, a platform designed for pick-and-place operations that eliminates the need for physical contact with components. Touchless Automation's technology is applicable in various industries, including aerospace, semiconductors, luxury watches, microsystems, and medtech, significantly enhancing production efficiency and yield by facilitating the handling of components ranging from 0.1 to 20 millimeters.

SwissProsthetics is a MedTech company based in Zurich, Switzerland, specializing in the development of 3D-printed prosthetic hands for children and adults with upper limb loss. The company offers an affordable and modular solution that does not require a specialist for fitting. Its prostheses consist of a shaft that connects to various hand modules, each designed for specific activities such as biking, swimming, and skiing. This innovative approach enables users to engage in daily activities more easily and effectively, catering to the unique needs of both children and adolescents.

Mirrakoi SA is a Swiss company specializing in the development of computer-aided design software, particularly for the medical field. Founded in 2018 as a spin-off from the Swiss Federal Institute of Technology in Lausanne, Mirrakoi offers an innovative solution known as Rhino3DMedical. This proprietary software facilitates a streamlined workflow that allows users to view, analyze, and segment medical images, ultimately creating 3D-printable anatomical models from CT and MRI scans. The technology is designed for orthopedic surgical planning, enabling the development of patient-specific models with ease through an intuitive interface and guided workflow. Mirrakoi's focus on enhancing the design process in the medical sector positions it as a leader in augmented design technology.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Positrigo develops and manufactures dedicated brain positron emission tomography (PET) scanners. Its mission is to make functional brain imaging accessible for early detection of neurodegenerative diseases like Alzheimer's, Lewy body dementia, vascular dementia, and frontotemporal dementia.